Subsequently, Zhong et al. collected the sera from 188 patients with MS, 266 patients with NMO, 209 patients with other inflammatory neurological diseases, 203 patients with other noninflammatory neurological disease, and 40 HCs in China; they tried to detect the anti-Kir4.1 antibodies in patients with MS using a cell-based assay [44]. The gene discussed is KCNJ10; the disease is myeloid sarcoma.